Red Mountain Mining poised to commence drilling at Red Valley lithium project
Having secured a land package of approximately 6000 acres surrounding its existing staked drill locations and completed the required archaeological surveying following a round of pre-drilling, RMX is now positioned to begin its exploration program once permitting is complete.
King said that the company is currently reviewing bids from local drilling contractors and he anticipates drill permits for the project will be finalised in the coming weeks with drilling to commence thereafter.
Discussing the exploration acreage, King said, “We are very pleased with the swift progress we have made at the Red Valley lithium project and importantly we have now secured a land package of approximately 6000 acres which provides a scale required for a significant lithium brines operation should we encounter commercial levels of lithium enrichment”.
Red Mountain looks to uncover the next Clayton Valley
RMX is hoping that Red Valley can deliver the same prolific results achieved in the Clayton Valley Basin, which earn-in partner, Bill Feyerabend, has noted bears geological similarities to Red Valley.
Feyerabend has been involved in various drilling programs in the Clayton Valley and over the course of this work he has developed a detailed geological model as to the characteristics of the lithium enrichment in that region, together with the qualities which allow traditional extraction techniques.
On this note he said, “My experience in the Clayton Valley led me to query why it was the sole lithium brine production location in the US, and analysis of that region’s physical characteristics and considerable research over the last two years has led to the identification of the Red Valley project as a geologic analog for the Clayton Valley”.
The following similarities were identified by Feyerabend:
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.